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ABSTRACT 33 
Background:  Latent class analysis (LCA) has been used extensively to identify (latent) 34 
phenotypes of childhood wheezing.  However, the number and trajectory of discovered 35 
phenotypes differed substantially between studies.  36 
Objective:  To investigate sources of variability affecting the classification of phenotypes, 37 
identify key time points for data collection to understand wheeze heterogeneity, and ascertain 38 
the association of childhood wheeze phenotypes with asthma and lung function in adulthood. 39 
Methods:  We used LCA to derive wheeze phenotypes among 3167 participants in the ALSPAC 40 
cohort who had complete information on current wheeze recorded at 14 time points from birth 41 
to age 16½ years.  We examined the effects of sample size, data collection age and intervals on 42 
the results, and identified time points.  We examined the associations of derived phenotypes 43 
with asthma and lung function at age 23-24 years. 44 
Results:  A relatively large sample size (>2000) underestimated the number of phenotypes 45 
under some conditions (e.g. number of time points <11).  Increasing the number of data points 46 
resulted in an increase in the optimal number of phenotypes, but an identical number of 47 
randomly selected follow-up points led to different solutions.  A variable selection algorithm 48 
identified 8 informative time points (months 18, 42, 57, 81, 91, 140, 157 and 166).  The 49 
proportion of asthmatics at age 23-24 years differed between phenotypes, while lung function 50 
was lower among persistent wheezers. 51 
Conclusions: Sample size, frequency, and timing of data collection have a major influence on 52 
the number and type of wheeze phenotypes identified by LCA in longitudinal data. 53 
Key Messages 54 
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• The number and the nature of wheeze phenotypes identified by latent class analysis are 55 
dependent on the sample size, frequency, timing and distribution of data collection time 56 
points, model dimensionality, and combinations of these factors. 57 
• Not all data collection points carry useful information in distinguishing wheeze 58 
phenotypes.  59 
Capsule Summary 60 
We determined dependence of phenotype discovery on frequency, timing and distribution of 61 
data collection, identifying eight informative, time-specific follow-up points from infancy to 62 
adolescence. 63 
Keywords 64 
Childhood asthma, wheeze phenotypes, longitudinal analysis, latent class analysis, ALSPAC 65 
Abbreviations used 66 
ALSPAC : Avon Longitudinal Study of Parents and Children 67 
PIAMA  : Prevention and Incidence of Asthma and Mite Allergy  68 
TCRS  : Tucson Children's Respiratory Study  69 
LCA  : Latent class analysis 70 
BIC  : Bayesian information criterion  71 
AIC  : Akaike information criterion  72 
LMR  : Lo–Mendell–Rubin  73 
ARI  : Adjusted Rand index 74 
GLI  : Global lung function initiative  75 
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INTRODUCTION 76 
Wheeze is a common symptom in the early years of life, with nearly one third of children 77 
experiencing it at least once before their third birthday.
1-3
  Although the symptoms of most 78 
infants with wheeze seem to remit by the time the child reaches school age
4
, infantile wheeze 79 
may also persist into later childhood and adulthood after a period of remission.
5, 6
  Conversely, 80 
the majority of patients with persistent asthma start wheezing in early childhood.
2
  However, at 81 
the onset of symptoms, patients with “transient wheeze” and “persistent wheeze” look very 82 
similar, and it is difficult to predict which of the early childhood wheezers will stop wheezing 83 
(and when), and which will develop persistent wheezing and asthma.  84 
Understanding the heterogeneity of wheezing disorders and distinguishing wheeze phenotypes 85 
in early childhood is critical to developing interventions targeted at those who will persist with 86 
wheezing into later childhood, and to avoid overtreatment of individuals with transient 87 
wheeze.
7
  Over the last two decades, substantial effort has been devoted to understanding the 88 
heterogeneity of childhood wheezing illness (reviewed in
7-10
). In general, population-based 89 
birth cohorts are regarded as the optimal data sources for understanding temporal patterns of 90 
wheezing, and relating them to different risk factors, since the information is collected 91 
prospectively and therefore free from recall bias.
11
  The initial approach of hypothesis testing 92 
using data on wheezing collected at ages three and six years in the Tucson Children’s 93 
Respiratory Study (TCRS) described three wheezing phenotypes (transient early, late-onset and 94 
persistent).
2
  This finding was confirmed in several independent cohorts.
3, 12, 13
  Subsequently, 95 
the methodology to discover “wheeze phenotypes” was extended to the use of unsupervised, 96 
data-driven approaches such as the latent class analysis (LCA).
1, 14-18
  These analyses revealed 97 
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different structure within the data and suggested the existence of one,
19, 20
 or two further 98 
intermediate phenotypes.
1, 17, 18
  It is important to emphasize that although “wheeze 99 
phenotypes” derived from different analyses tend to share the same nomenclature, 100 
phenotypes with the same assignment often differ substantially in terms of the age of onset, 101 
temporal trajectory, distributions within a population
8
 and associated risk factors, making 102 
comparison between studies difficult, and clinical application uncertain.
8, 10
  For example, late-103 
onset wheezers were reported to start experiencing symptoms after the age of three,
19
 four,
16
 104 
or
 
five years
13
 in different studies.  The inconsistencies between studies may be partly 105 
attributed to differences in study design or could be due to true differences between different 106 
populations.  However, this seems unlikely, as most evidence comes from broadly similar 107 
population-based studies with comparable ethnic mixes. 108 
If we are to understand factors associated with patterns of wheezing with different long-term 109 
consequences, then “phenotypes” must be consistent and reproducible.  Despite the 110 
widespread use of LCA, little is known about the external factors that influence the outcomes of 111 
LCA models in phenotype identification.  We propose that sample size and the timing and 112 
frequency of data collection affect the number and type of discovered wheeze phenotypes in 113 
LCA, and that not all time points carry useful information (and therefore some might be 114 
redundant, or even cause uncertainty in the results).  To provide a better understanding of the 115 
influence of input data characteristics on the identified longitudinal trajectories of wheezing, 116 
we investigated the effect of the number of data points, age at which information was 117 
collected, and sample size on the number and/or the nature of wheeze phenotypes discovered 118 
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by LCA.  We also sought to identify data collection points which are most informative in 119 
distinguishing wheeze phenotypes.    120 
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METHODS 121 
Study design, setting and participants 122 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a populaOon-based birth 123 
cohort established in 1991 in Avon, UK.  It recruited 14,701 children born between 1
st
 April 1991 124 
and 31
st
 December 1992.  Ethical approval for the study was obtained from the ALSPAC Ethics 125 
and Law CommiPee and Local Research Ethics CommiPees.  Details of the study protocol can be 126 
found elsewhere.
21
  The study website contains details of all the data that are available through 127 
a fully searchable data dicOonary at www.bris.ac.uk/alspac/researchers/data-access/data-128 
dicOonary/.   129 
Data sources and deﬁni,on of outcomes 130 
ParOcipaOng mothers were sent a self-compleOon quesOonnaire about the health of their child 131 
at 14 Ome points from birth to age 16½ years: months 6, 18, 30, 42, 57, 69, 81, 91, 103, 128, 132 
140, 157, 166 and 198.  Current wheeze was deﬁned as a positive answer to the question “In 133 
the last 12 months has he/she had any periods when there was wheezing or wheezing with 134 
whistling on his/her chest when he/she breathed?”.
22
   135 
Study subjects aPended research clinic at age 23-24 years in which lung funcOon was measured 136 
using spirometry.
23, 24
  Post-bronchodilator FEV1 was ascertained 15 minutes aTer 137 
administraOon of 400 mcg of salbutamol.  We expressed FEV1 as % predicted against the GLI-138 
curves.
25
  Self-reported asthma ever was deﬁned as a posiOve answer to the quesOon “Have you 139 
ever had asthma?”.  Self-reported current asthma was deﬁned at age 23 years as asthma ever 140 
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together with a posiOve answer to either “Have you had any wheezing or whistling in the past 141 
12 months?” or “Have you taken asthma medicaOon in the last 12 months?”. 142 
Statistical analysis 143 
Children with complete reports of wheezing at all 14 Ome points from birth to age 16½ years 144 
(n=3167) were included in the analysis to obtain bePer representaOon of the latent structure.  145 
We performed LCA to invesOgate how latent class subpopulaOon structure varied by the Oming 146 
and frequency of observaOons.  StarOng with a latent model including 4 phenotypes, we 147 
compared models with varying sample sizes (3167, 2500, 2000, 1500, 1000 and 500), number of 148 
latent classes (4 to 6) and number of Ome points (14, 11, 8 and 6) based on their staOsOcal ﬁt, 149 
including the Akaike informaOon criterion (AIC), Bayesian informaOon criterion (BIC), Lo–150 
Mendell–Rubin (LMR) and Bootstrapped likelihood raOo, model quality (model entropy) and 151 
interpretability.  The best ﬁWng model in each run was selected based on the lowest BIC.  We 152 
then repeated our analyses among 12,290 parOcipants with at least 2 quesOonnaire responses.  153 
We idenOﬁed criOcal data collecOon points for the idenOﬁcaOon of disOnct phenotypes of 154 
wheeze based on stochasOc evoluOonary search via a geneOc algorithm (see Online Repository 155 
for more details on the methodology for selecOon of informaOve data collecOon points).  The 156 
Adjusted Rand Index (ARI) was used as a similarity measure when comparing diﬀerent clustering 157 
results.  Variable speciﬁc entropy values were used to show how well individual data collecOon 158 
points idenOfy the latent classes.  We calculated Confidence Intervals (Cis) for the difference of 159 
population proportions to compare the frequency of participants with asthma at age 23 years 160 
between different phenotypes.  Differences in lung function were tested using one-way ANOVA 161 
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and Tukey’s HSD (honestly significant difference) test.  All analyses were performed in Stata 162 
v15, Mplus 8, and R using the packages poLCA,
26
 DiagrammeR and LCAvarsel.
27
   163 
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RESULTS 164 
A total of 3167 participants had complete reports of wheeze at all 14 time points.  In line with 165 
our previous results,
17, 18
 the best-fitting model resulted in six distinct wheezing phenotypes: 166 
Never/infrequent wheeze; Persistent wheeze; two early-onset transient classes (Early-onset 167 
preschool remitting and Early onset mid-childhood remitting); and two late-onset persisting 168 
classes (School age-onset and Late childhood-onset).  169 
Influence of sample size 170 
We varied the sample size from 3167 to 500, and developed 11 different models based on 171 
randomly selected sub-samples of six different sizes (N=500, 1000, 1500, 2000, 2500 and 3167), 172 
holding all else constant.  Figure 1a shows the best-fitting models based on different sample 173 
sizes and the prevalence of each phenotype based on the estimated model.  Four phenotypes 174 
(Never/infrequent, Persistent, Transient early and Late onset) were identified with a sample 175 
size of 500.  The best fitting model based on 1000 participants resulted in four to five 176 
phenotypes. 177 
Larger sample sizes (2000 participant or more) were needed to detect smaller phenotypes (<5% 178 
frequency).  LCA identified six latent wheeze phenotypes in samples of ≥2000 children with 179 
complete data (Figure 1a), and in samples of ≥5000 children with incomplete data (Figure E2). 180 
Influence of data collection frequency 181 
We then varied the frequency of data collection time points from 6 to 14, and developed 10 182 
different models based on randomly selected time points while maintaining a constant sample 183 
size (N=3167).  Adding more time points to the latent model increased the number of wheeze 184 
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phenotypes that were identified (Figure 1b).  However, in some cases, an identical number of 185 
(randomly selected) data collection points (e.g. 11 time points) resulted in different optimal 186 
number of phenotypes, depending on the intervals between time points.  This suggests that, in 187 
addition to sampling frequency, timing and distribution of time points at which data are 188 
collected may influence wheeze phenotype identification, and that there might be critical data 189 
collection points which are more informative in distinguishing wheeze phenotypes.  190 
Combined effects of sample size and data collection frequency 191 
To examine how both the frequency of data collection (number of time points) and the size of 192 
the studied population affects the optimal number, trajectory, and frequency of the identified 193 
phenotypes, we varied the number of data collection points from 6 to 11 and randomly 194 
selected sub-samples of four different sizes, resulting in a total of 12 data conditions (Figure 195 
1c). 196 
Models with small sample sizes (N<2500) did not identify low-frequency phenotypes (<5%), 197 
regardless of the frequency of data sampling.  However, there was a clear link between sample 198 
size, number of data points and the optimal number of wheeze phenotypes.  The model with 199 
sample size of ≥2500 identified six phenotypes when the number of data collection points 200 
included in the analysis was relatively high.  However, models with decreasing number of data 201 
points were unable to detect six phenotypes, and models with the same sample size did not 202 
identify small phenotypes (<5% frequency) under certain conditions (e.g. number of time points 203 
<11). 204 
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Selection of the most informative data collection points 205 
Figure E1 shows the correlations (phi coefficients) between wheeze reports at different time 206 
points.  Time points close to each other were moderately correlated (e.g. month 157 and 166; 207 
month 81 and 91 etc.), suggesting that some of the adjacent time points convey similar 208 
information.  In order to discard the non-informative data collection points, we performed 209 
stochastic evolutionary search via a genetic algorithm, which retained 8 informative time points 210 
(months 18, 42, 57, 81, 91, 140, 157, and 166), while 6 were dropped as uninformative (months 211 
6, 30, 69,103, 128 and 198).  Comparing the clustering of the models using eight time points to 212 
the clustering from the model using the full dataset showed a satisfactory level of agreement, 213 
with Rand and Adjusted Rand indices of 82 and 64%, respectively (Table 1).  214 
Latent transition probabilities with increasing number of classes 215 
To understand how the trajectories and estimated phenotypes changed over a sequence of 216 
increasing number of classes, and how children move from one class to another in models with 217 
an increasing number of classes, we developed three LCA models with four, five and six classes.  218 
Persistent and never/infrequent wheeze classes had similar patterns in all three models, with a 219 
slight decrease in estimated prevalence from four to six-class solution (Figure 2 panel A).  With 220 
the addition of a fifth latent class, Transient-early wheeze divided into two remitting classes 221 
(Pre-school and Mid-childhood resolution, Figure 2 panel B), while the Late-onset wheeze 222 
remained almost identical.  The addition of a sixth class resulted in the division of the Late-223 
onset wheeze into two similar-sized sub-groups (School-age and Late childhood onset, Figure 2 224 
panel C).  We then assigned participants to the most likely phenotype based on the maximum 225 
membership probability, and calculated transition probabilities reflecting the proportion of 226 
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participants moving from one phenotype to another when the number of phenotypes increased 227 
from four up to six.  Figure 3 shows whether members of distinct phenotypes remained in the 228 
same phenotype or shift into another one (either existing or newly formed) with increasing 229 
number of phenotypes.  The figure also demonstrates where the intermediate phenotypes arise 230 
from, and which phenotypes become separated or remain undivided with increasing number of 231 
latent classes.  The results based on analysis of participants with incomplete reports of wheeze 232 
(12,290 participants with at least 2 responses to questionnaires about wheezing) did not 233 
materially differ from those obtained among children with complete data set and are presented 234 
in this article’s Online Repository (Figures E2-E6). 235 
Asthma and lung function in adulthood in different wheeze phenotypes  236 
Of 3797 participants who attended age 23-24 years follow-up, 1492 had complete reports of 237 
wheezing (14 points), of whom 240 (16%) reported current asthma; 1345 had valid lung 238 
function.  The proportion of subjects with current asthma was highest in the Persistent wheeze 239 
(99.7%), Table 2.  In the two early-onset transient phenotypes, the proportion of asthmatics 240 
was significantly higher in Mid-childhood remitting (60.4%) compared to the Pre-school 241 
remitting (6.4%) (Mean difference 0.54, 95%CI 0.40-0.68, p<0.0001).  In the two late-onset 242 
phenotypes, the proportion of asthmatics was significantly higher in School-age onset (88.4%) 243 
compared to Late-childhood onset (68.1%) (Mean difference 0.20, 95%CI 0.05-0.36, p<0.02).  244 
Pre- and post-bronchodilator lung function differed significantly across phenotypes (p=0.005 245 
and p=0.04 respectively, ANOVA), and was significantly lower in Persistent wheeze and Early-246 
onset pre-school remitting wheeze compared to Never/infrequent wheeze, with little evidence 247 
of differences between other phenotypes (Tables 3, E1-3).  The Preschool-onset remitting 248 
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phenotype mostly overlapped with no asthma (94%), but the pre- and post-bronchodilator lung 249 
function at age 24 was significantly lower in this class compared to Never/infrequent wheeze.   250 
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DISCUSSION 251 
Key results 252 
Our results suggest that the number and the nature of wheeze phenotypes from infancy to 253 
adolescence identified by LCA are dependent on several factors including sample size, 254 
frequency, timing and distribution of data collection time points, model dimensionality, as well 255 
as the combination of these factors.  Transition analysis revealed that subjects assigned to 256 
Never or Persistent wheeze tend to stay in these phenotypes, whilst most of the switching goes 257 
on in the intermediate classes.  Given the strong interplay between the birth cohort design 258 
(including the number of participants, data collection frequency and distribution) and the 259 
optimal number of phenotypes identified by means of developmental trajectory modelling, 260 
care should be taken when interpreting wheeze phenotypes emerging from small studies with 261 
few data collection points.  When the sample size is small, a wheeze phenotype that exists in 262 
the population may be unidentifiable, whereas excessive data collection may result in the 263 
identification of trivial or clinically irrelevant phenotypes.  In general, increasing data collection 264 
frequency helps detect more complex structure and larger number of phenotypes by capturing 265 
less-frequently observed subgroups.  However, it also increases the risk of violating the 266 
fundamental assumption of LCA modelling where indicator variables (e.g. presence/absence of 267 
wheeze at subsequent ages) are independent of each other.  When frequent data collection 268 
and large sample sizes are not obtainable, collecting data at critical time points may help 269 
counterbalance the effects of sub-optimal conditions (e.g. smaller sample size and infrequent 270 
data collection).  In our study, time points which proved most informative in distinguishing 271 
wheeze phenotypes were months 18, 42, 57, 81, 91, 140, 157 and 166. 272 
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Limitations 273 
There are several limitations to our findings.  Despite latent models’ usefulness in disentangling 274 
disease complexity, one unresolved issue in the application of LCA is that there is not one 275 
commonly accepted statistical indicator for deciding on the number of subgroups in a study 276 
population.  The limitation of this study is that we do not know how many true phenotypes 277 
there are, and we assumed that the classification obtained on the largest sample and using all 278 
time points corresponded to the best-available approximation of the ‘true classification’.  In the 279 
absence of clear statistical requirements for identifying clinically important groups of small size, 280 
validation of the phenotypes with late asthma outcomes provides the only clues about their 281 
clinical relevance.  However, we acknowledge that in our study information on asthma and lung 282 
function measures at age 23-24 years was available for ~45% of participants used to derive 283 
wheeze phenotypes. 284 
Another limitation is that we could only vary conditions using the sampling framework that was 285 
available to us, which was fixed by the study design, so this analysis has limited direct 286 
application to other studies that have used different sampling frames.  We also acknowledge 287 
that the definition of current wheeze which we used in our models is based on parental 288 
reporting using validated questionnaires (as in most other epidemiological studies) and that this 289 
may lead to overestimation of the true prevalence.
28
  290 
As most previous studies, we used information on current wheeze for our modelling.  It is 291 
possible that a more holistic examination of other features (e.g. frequency and severity of 292 
wheeze) and/or other symptoms (e.g. cough, atopic dermatitis and rhinitis)
22
 and lung 293 
function
29
 may allow better distinction of the underlying pathophysiological mechanisms. 294 
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The key advantage of our study is the large sample size with complete data on wheezing 295 
collected frequently and prospectively.  Another advantage is that participants were followed 296 
from birth to late adolescence, covering a longer period compared to most prior studies.
1, 13, 18, 
297 
19, 30
    298 
Finally, it is worth noting that subtypes discovered using data-driven methods are not observed, 299 
but are latent by nature, and ideally should not be referred to as “phenotypes” (i.e. observable 300 
characteristics).  However, as the term “phenotype” has been used in this context for over a 301 
decade, we have maintained this nomenclature. 302 
Interpretation 303 
A number of previous studies (including our own) embarked on identifying wheeze phenotypes 304 
from birth to mid-school age (summarized in Table E4).  However, the inconsistency of ﬁndings 305 
has led to a debate on the validity and clinical value of phenotyping studies,
10, 31, 32
 hampering 306 
the discovery of pathophysiological endotypes and translation into clinically actionable insights.  307 
The four phenotypes of persistent, never, transient early and late-onset wheeze have been long 308 
postulated in descriptive,
2
 and data-driven studies.
33
   We found that when the sample size is 309 
relatively small, a particular wheeze phenotype that exists in the population may be 310 
undetectable.  Therefore, relatively smaller sample size in some studies might have contributed 311 
to the inability to detect intermediate wheeze phenotypes with a relatively low prevalence.  312 
Using more time points allowed the identification of less common phenotypes (<5% frequency) 313 
by increasing possible response patterns.  When the data collection was frequent (>11 time 314 
points), a sample size of ~2500 was found to be sufficiently large to distinguish six phenotypes.  315 
However, even a larger sample size of 3167 might be insufficient to detect uncommon 316 
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phenotypes (<5% frequency) under certain conditions (e.g. data collection points <11).  Our 317 
findings suggest that increasing data collection frequency may help compensate for a modest 318 
sample size in phenotype identification.  In line with this finding,  Depner et al.
30
 identified an 319 
intermediate phenotype in the PASTURE cohort that existed during the first six years of life, 320 
using a similar sample size but more data collection points than those used in the TCRS.
2
  321 
However, the selection of follow up points needs a careful thought.  Our analyses have shown 322 
that although adding more time points to the latent model increased the number of identified 323 
phenotypes with distinguishable interpretations, in some cases the same number of randomly 324 
selected data collection points resulted in a different optimal solution.  This suggests that the 325 
timing and distribution of follow-ups is important, and that there might be critical data 326 
collection points which are more informative than others.  A variable selection method which 327 
we applied to the data identified 6 time points which were not carrying additional useful 328 
information (months 6, 30, 69, 103, 128 and 198).  329 
The proportion of asthmatics was highest in the Persistent wheeze (98.5%), and subjects in this 330 
phenotype had diminished pre and post-bronchodilator lung function (at the time of maximally 331 
attained physiological lung function plateau
29
) compared to all other phenotypes.  The 332 
proportion of asthmatics differed between intermediate phenotypes (15.1% and 75.3% in two 333 
transient early phenotypes, Pre-school remitting and Mid-childhood remitting respectively; 334 
91.3% and 70.0% in two late-onset phenotypes, Late childhood and School-age onset).  These 335 
findings suggest that all phenotypes are distinct and that this may be a true classification.  336 
However, we acknowledge that the observed associations may also be a proxy of severity. 337 
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The preschool-onset remitting phenotype mostly overlapped with no asthma (94%) but the pre 338 
and post-bronchodilator lung function at age 24 was significantly lower in this class compared 339 
to Never/infrequent wheeze.  Although this may be seen as a contradiction, we would stress 340 
that diminished lung function does not equate to asthma.
29
 There is evidence that early 341 
transient wheeze is associated with low lung function
34-37
; as lungs/airways grow the symptoms 342 
regress but lung function impairments may persist. In TCRS, the lowest infant lung function test 343 
values were associated with low lung function at 22 years
38
; so early wheeze that remits may be 344 
a marker of low lung function in early life that persists to adulthood, but without the 345 
development of airway inflammation or asthma. 346 
In conclusion, our findings add to the understanding of childhood wheeze phenotypes by 347 
extending the knowledge on potential causes of variability in classification of wheezing.  Sample 348 
size, frequency, and timing of data collection have a major influence on the number and type of 349 
phenotypes identified by data-driven techniques.  Our results, which include information on the 350 
most informative follow-up points, are important to interpret (or reanalyze) existing studies 351 
and to inform better design of future cohorts.  However, we wish to note that these data 352 
collection points should not be regarded as absolute; rather, they should be treated as relative 353 
values with respect to our population, and considerations for investigators when designing 354 
future studies. 355 
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LEGEND FOR FIGURES 
 
Figure 1.  The opOmal number, shape and prevalence of wheeze phenotypes idenOﬁed by using 
latent class analysis: 
a) 11 latent models based on randomly selected sub-samples of six diﬀerent sample sizes 
(N=500, 1000, 1500, 2000, 2500 and 3167) while maintaining a constant number of follow-up 
points (14 Ome points)  
b) 10 latent models based on randomly selected time points (6, 8, 11 and 14 TPs) while 
maintaining a constant sample size (N=3167)  
c) 12 latent models based on randomly selected sub-samples of four diﬀerent sample sizes 
(N=500, 1500, 2500 and 3167) and diﬀerent number of time points (6, 8 and 11 TPs)  
 
Figure 2.  Estimated prevalence of wheeze for each wheezing phenotype in four-, five- and six- 
latent class solutions identified by LCA  
 
Figure 3.  Assignment of children into distinct wheeze phenotypes over a sequence of LC model 
with four, five and six classes based on most likely class membership (3167 children cohort with 
complete reports of wheezing at 14 time points).  Ellipse nodes show class membership (most 
likely phenotype) whilst the values along the arrow represent the % of children moving from 
one class to another in models with an increasing number of classes.  
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Table 1: Clustering summary of the LCA model fitted to the data sub-set (8 time points 
identified via a genetic algorithm search) and its comparison the model fitted to the full dataset 
(14 data collection points): based on 3167 participants with complete information on current 
wheeze recorded at 14 time points 
 
Model Characteristics 
 
Variable Selection (stochastic search) 
 
 
No. of classes 
 
6 
 Selected time 
points (months) 
Univariate 
entropy 
 
BIC 
 
15508 
  
18 
 
0.502 
 
  
42 
 
0.581 
 
Entropy 
 
0.87 
  
57 
 
0.590 
  
81 
 
0.578 
Rand Index 
Adjusted Rand Index 
0.82 
0.64 
  
91 
 
0.588 
  
140 
 
0.549 
 
Jaccard Index 
 
0.70 
  
157 
 
0.576 
  
166 
 
0.582 
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Table 2: Proportion of asthmatics at age 23-24 in each phenotype 
 
Wheezing Phenotypes 
0-16½ years 
Self-reported 
asthma ever 
 
Current asthma 
 at age 23 
 Asthma medication use 
at age 23 
No. of 
asthmatics/total 
  Percent*  
         No. of 
asthmatics/total 
  Percent*  
 No. of med. 
users/total 
       Percent* 
Never-
infrequent  
 105/1111  9.4 50/985  5.1  33/985  3.3 
Pre-school 
remitting  
T
ra
n
si
e
n
t 
e
a
rl
y 54/355  15.1  19/295  6.4  9/295  3.2 
Mid-childhood 
remitting 
72/95  75.3  30/49  60.4  14/49  29.5 
School-age 
onset  
La
te
-o
n
se
t 56/61  91.3  38/43  88.4  25/43  58.3 
Late-childhood 
onset  
58/82  70.0  38/55  68.1  25/55  45.3 
Persistent 
wheeze 
 81/82  98.5  65/65  99.7  53/65  82.1 
*The percentage is estimated from weighted cross tabulations. 
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Table 3: Lung function at age 24 years by wheeze phenotype (restricted to 1343 participants with FEV1 % predicted data and 1351 
with FEV1/FVC data) 
 
Wheezing Phenotypes 0-16½ years 
Baseline lung function at 24y  Post-bronchodilator lung function at 24y 
FEV1 % predicted FEV1/FVC  FEV1 % predicted FEV1/FVC 
No. Mean (SD) No. Mean (SD)  No Mean (SD) No. Mean (SD) 
Never-infrequent 1004 95.0 (11.7)  1009 0.84 (0.06)  830 97.9 (11.7)  834 0.86 (0.06) 
Pre-school remitting 
T
r
a
n
s
i
e
n
t
 
e
a
r
l
y
 
329 93.4 (11.4)  330 0.82 (0.07)  274 96.8 (10.9)  275 0.85 (0.06) 
Mid-childhood remitting 89 93.5 (11.4)  91 0.82 (0.06)  71 97.5 (11.8)  73 0.84 (0.05) 
School-age onset 
L
a
t
e
-
o
n
s
e
t
 
61 95.4 (11.2)  61 0.81 (0.08)  47 100.8 (10.8)  47 0.86 (0.06)
 
Late-childhood onset 79 94.0 (12.1)  80 0.82 (0.07)  62 98.7 (10.8)  63 0.85 (0.05) 
Persistent wheeze 80 91.6 (12.4)  80 0.79 (0.09)  59 96.5 (11.1)  59 0.83 (0.07) 
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METHODS 
Study design: Unselected birth cohort study.  
Setting: ALSPAC is based on the former administrative County of Avon, United Kingdom 
covering a population of approximately 0.9 million.  
Screening and recruitment: ALSPAC initially recruited 14,541 pregnant women resident in Avon, 
UK with expected dates of delivery between April 1, 1991 and December 31, 1992.  This initial 
number of pregnancies, known as core sample, included the mothers enrolled in the ALSPAC 
study and had either returned at least one questionnaire or attended a ‘Children in Focus’ 
research clinic by 19
th
 July 1999.  These initial pregnancies had a total of 14,676 fetuses, 
resulting in 14,062 live births and 13,988 children who were alive at age 1 year.  When the 
oldest children were approximately seven years of age, an attempt was made to bolster the 
initial sample with eligible cases who had failed to join the study originally.  As a result, there 
are extra data available when considering variables collected from the age of seven years 
onwards.  The number of new pregnancies, not in the core sample, known as phases II and III 
enrolments, is 706 (452 and 254 recruited during Phases II and III respectively), resulting in an 
additional 713 children being enrolled.  The phases of enrolment are described in more detail in 
the cohort profile paper.
1,2
  Therefore, the total sample size for analyses using any data 
collected after the age of seven years is therefore 15,247 pregnancies, resulting in 15,458 
fetuses with 14,775 live births and 14,701 alive children at 1 year of age. 
Spirometry: Performed according to American Thoracic Society/European Respiratory Society 
guidelines,
3,4
 using a Vitalograph pneumotachograph system with animated incentive software 
(Spirotrac, Vitaograph, UK) in a dedicated research clinic by trained technicians.  Calibration 
checks were performed with a standard 3L calibration syringe according to the manufacturer’s 
instructions at the start of each half-day clinic session.  Subjects were seated with a nose clip in 
place and were asked to inhale to total lung capacity (TLC), then instructed to perform a forced 
expiration, through a mouthpiece, to residual volume (RV).  The test was repeated at intervals 
of 30 seconds until 3 technically acceptable traces were obtained from a maximum of eight 
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attempts.  Forced expiratory volume in one second (FEV1) and Forced vital capacity (FVC) were 
recorded and the data expressed as FEV1 % predicted and FEV1/FVC ratio. 
Definition of outcomes  
Current wheeze: Positive answer to the question “In the last 12 months has he/she had any 
periods when there was wheezing or wheezing with whistling on his/her chest when he/she 
breathed?”  
Current asthma: Self-reported current asthma at 23 years based on asthma ever at 22+ 
together with current wheezing and/or current treatment: “Have you had any wheezing in the 
past 12 months?” and/or “Have you taken asthma medication in the last 12 months?”. 
Asthma ever: Positive answer to the question “Have you ever had asthma?” at age 22+. 
Study data were collected and managed using REDCap electronic data capture tools hosted at 
ALSPAC facilities.
5
 Please note that the study website contains details of all the data that is 
available through a fully searchable data dictionary and variable search tool 
(http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/). 
 
Statistical analysis 
Measures of ﬁt in LCA  
An opJmal model is deﬁned as the free model that best ﬁts the data.  To assess model ﬁt, we 
used (1) the Bayesian informaJon criterion (BIC), a funcJon of the likelihood that rewards 
parsimony and (2) entropy, an assessment of model classiﬁcaJon based on the posterior class 
membership probabiliJes.  The BIC is an index used in Bayesian staJsJcs to choose among a set 
of compeJng models; the model with the lowest BIC is preferred.  Entropy is a measure of 
classiﬁcaJon certainty that that ranges from 0 to 1, with values near 1 indicaJng a clear 
delineaJon of classes and values near 0 indicaJng low certainty in classiﬁcaJon. 
Selecon of informave data collecon points 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4 
 
A genetic algorithm was employed to search for the optimal set of clustering variables (e.g. 
time points) to distinguish wheeze subgroups, using the LCAvarsel R package.
6
 During the 
search, multiple sets of clustering variables were considered at the same time; then, for each 
set, a latent class analysis model was estimated on the clustering variables and a 
regression/independence model was estimated on the non-clustering ones. Different sets were 
generated by various genetic operators and the fittest individuals were selected.  The fitness 
function was defined as the BIC of the joint distribution of both clustering and non-clustering 
variables, where clustering variables were modeled via a latent class analysis model and non-
clustering variables were modeled via multinomial logistic regression.  Variable specific entropy 
contribution of each time point was used to assess how well individual time points identified 
the latent classes.  These univariate entropies varying between 0 and 1 were directly 
comparable to each other, with large values indicating the clear separation of classes.  The 
Rand Index (RI) and Adjusted Rand Index (ARI) was used as a similarity measure when 
comparing different clustering results.  More specifically, ARI was used to measure the level of 
agreement between two partitions, the model fitted to the data subset and the full dataset.  A 
larger RI and ARI means a higher agreement between two partitions. 
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LEGEND FOR FIGURES 
Figure E1.  Heatmap showing the phi coeﬃcient of pairwise comparison between data 
collecJon points 
 
Figure E2.  The opJmal number, shape and prevalence of wheeze phenotypes with diﬀerent 
(12,290, 7500, 5000, 2500, 1500, 500) sample sizes based on children with at least 2 
observaJons of wheeze (the opJmal was chosen based on the lowest BIC) 
 
Figure E3.  The opJmal number, shape and prevalence of wheeze phenotypes with diﬀerent 
number of data collecJon points (6, 8, 11 and 14) based on children with at least 2 observaJons 
of wheeze.  
 
Figure E4.  The opJmal number, shape and prevalence of wheeze phenotypes with combined 
eﬀects of sample size and data collecJon frequency based on children with at least 2 
observaJons of wheeze.  
 
Figure E5.  Estimated prevalence of wheeze for each wheezing phenotype in four-, five- and six- 
latent class solutions identified by LCA based on children 12,290 children with at least 2 
observaJons of wheeze 
 
Figure E6.  Assignment of children into distinct wheeze phenotypes over a sequence of LC 
model with four, five and six classes based on most likely class membership (12,290 children 
with at least 2 observaJons of wheeze).  Ellipse nodes show class membership (most likely 
phenotype) whilst the values along the arrow represent the % of children moving from one 
class to another in models with an increasing number of classes.
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Table E1: Differences of lung function (FEV1 % predicted) at 24 years between wheezing phenotypes: ANOVA and Tukey HSD test of 
pairwise comparisons. 
ANOVA 
Variation 
 source 
df Sum square Mean square F value Pr(>F) 
Pre-BD           
FEV1 % pred. 
Post-BD     
FEV1 % pred. 
Pre-BD        
FEV1 % pred. 
Post-BD    FEV1 
% pred. 
Pre-BD        
FEV1 % pred. 
Post-BD            
FEV1 % pred. 
Pre-BD      FEV1 
% pred. 
Post-BD       
FEV1 % pred. 
Pre-BD      
FEV1 % pred. 
Post-BD    
FEV1 % pred. 
Phenotypes 5 5 2243 1463 448.6 292.6 3.313 2.252 0.005561 0.04709 
Residual 1651 1351 223565 175521 135.4 129.9     
Tukey’s HSD (Honestly Significant Difference) Test 
Pairwise comparison of wheeze phenotypes 
Mean Differences Significant (p adjusted<0.05)? 95 % Cl of differences (lower, upper) 
Pre-BD FEV1 % 
pred. 
Post-BD 
FEV1% pred 
Pre-BD FEV1% 
pred. 
Post-BD FEV1 % 
pred. 
Pre-BD   
         FEV1 % pred. 
Post-BD     
     FEV1 % pred. 
Mid-childhood remitting AND Late-childhood onset -0.66 -1.61 No No (-5.82, 4.49) (-7.27, 4.05) 
Never/infrequent AND Late-childhood onset 0.69 -1.34 No No (-3.11, 4.50) (-5.52, 2.84) 
Pre-school remitting AND Late-childhood onset -1.59 -3.11 No No (-5.78, 2.60) (-7.69, 1.47) 
Persistent AND Late-childhood onset -3.26 -3.41 No No (-8.44, 1.93) (-9.26, 2.44) 
School-age onset AND Late-childhood onset 1.51 1.70 No No (-4.11, 7.12) (-4.45, 7.86) 
Never/infrequent AND Mid-childhood remitting 1.36 0.27 No No (-2.40, 5.12) (-3.85, 4.39) 
Pre-school remitting AND mid-childhood remitting -0.93 -1.50 No No (-5.08, 3.22) (-6.03, 3.03) 
Persistent AND Mid-childhood remitting -2.59 -1.80 No No (-7.75, 2.56) (-7.61, 4.00) 
School-age onset AND Mid-childhood remitting 2.17 3.31 No No (-3.42, 7.76) (-2.80, 9.43) 
Pre-school remitting AND Never/infrequent -2.29 -1.77 Yes No (-4.55, -0.02) (-4.20, 0.66) 
Persistent AND Never/infrequent -3.95 -2.07 Yes No (-7.76, -0.15) (-6.45, 2.30) 
School-age onset AND Never/infrequent 0.81 3.04 No No (-3.56, 5.18) (-1.73, 7.82) 
Persistent AND Pre-school remitting -1.66 -0.30 No No (-5.86, 2.52) (-5.06, 4.46) 
School-age onset AND Pre-school remitting 3.10 4.81 No No (-1.61, 7.81) (-0.32, 9.94) 
School-age onset AND Persistent 4.77 5.12 No No (-0.85, 10.38) (-1.17, 11.4) 
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Table E2: Differences of lung function (FEV1/FVC ratio) at 24 years between wheezing phenotypes: ANOVA and Tukey HSD test of 
pairwise comparisons. 
ANOVA 
Variation 
 source 
df Sum square Mean square F value Pr(>F) 
Pre-BD 
FEV1/FVC ratio 
Post-BD 
FEV1/FVC ratio 
Pre-BD 
FEV1/FVC ratio 
Post-BD 
FEV1/FVC ratio 
Pre-BD 
FEV1/FVC 
ratio 
Post-BD    
FEV1/FVC ratio 
Pre-BD 
FEV1/FVC ratio 
Post-BD 
FEV1/FVC ratio 
Pre-BD 
FEV1/FVC ratio 
Post-BD 
FEV1/FVC ratio 
Phenotypes 5 5 0.3269 0.1527 0.06539 0.03054 14.51 8.33 6.2E-14 9.0E-08 
Residual 1600 1358 7.482 4.977 0.00451 0.00366     
Tukey’s HSD (Honestly Significant Difference) Test 
Pairwise comparison of wheeze phenotypes 
Mean Differences Significant (p adjusted<0.05)? 95 % Cl of differences (lower, upper) 
Pre-BD  
FEV1/FVC ratio 
Post-BD 
 FEV1/FVC ratio 
Pre-BD  
FEV1/FVC ratio 
Post-BD FEV1/FVC 
ratio 
Pre-BD   
 FEV1/FVC ratio 
Post-BD 
 FEV1/FVC ratio 
Mid-childhood remitting AND Late-childhood 0.01 -0.01 No No (-0.02, 0.04) (-0.04, 0.02) 
Never/infrequent AND Late-childhood onset 0.02 0.01 No No (0.00, 0.04) (-0.02, 0.03) 
Pre-school remitting AND Late-childhood onset 0.00 -0.01 No No (-0.03, 0.02) (-0.04, 0.01) 
Persistent AND Late-childhood onset -0.03 -0.03 No No (-0.06, 0.00) (-0.06, 0.00) 
School-age onset AND Late-childhood onset 0.00 0.00 No No (-0.04, 0.03) (-0.03, 0.03) 
Never/infrequent AND Mid-childhood remitting 0.01 0.02 No No (-0.01, 0.04) (0.00, 0.04) 
Pre-school remitting AND mid-childhood -0.01 0.00 No No (-0.04, 0.01) (-0.02, 0.02) 
Persistent AND Mid-childhood remitting -0.03 -0.02 Yes No (-0.06, 0.00) (-0.05, 0.01) 
School-age onset AND Mid-childhood remitting -0.01 0.01 No No (-0.04, 0.02) (-0.02, 0.04) 
Pre-school remitting AND Never/infrequent -0.03 -0.02 Yes Yes (-0.04, -0.01) (-0.03, -0.01) 
Persistent AND Never/infrequent -0.05 -0.04 Yes Yes (-0.07, -0.03) (-0.06, -0.01) 
School-age onset AND Never/infrequent -0.03 -0.01 Yes No (-0.05, 0.00) (-0.03, 0.02) 
Persistent AND Pre-school remitting -0.02 -0.02 No No (-0.05, 0.00) (-0.04, 0.01) 
School-age onset AND Pre-school remitting 0.00 0.01 No No (-0.03, 0.03) (-0.01, 0.04) 
School-age onset AND Persistent 0.02 0.03 No No (-0.01, 0.05) (0.00, 0.06) 
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Table E3: The FEV1 reversibility at age 24 years by phenotype (restricted to 1364 participants with FEV1 reversibility data) 
Wheezing Phenotypes 0-16½ years 
 
             FEV1 reversibility at 24y P-value* 
(optional) % positive 
FEV1 reversibility 
No. Mean (SD) 
Never-infrequent 898 2.87 (6.2) Baseline 80.0 
Pre-school remitting 
T
r
a
n
s
i
e
n
t
 
e
a
r
l
y
 
224 4.02 (5.4) 0.104 81.3 
Mid-childhood remitting 69 4.03 (5.3) 0.627 84.1 
School-age onset  
L
a
t
e
-
o
n
s
e
t
 
49 4.94 (4.9) 0.171 89.8 
Late-childhood onset  65 4.22 (5.4) 0.490 83.1 
Persistent wheeze 59 6.29 (5.9) 0.0003 91.5 
    * Tukey test. 
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Table E4: Wheeze phenotypes from birth up to 9 years of age identified based on temporal 
pattern 
Cohort Sample Size 
Number of time 
points 
Years covered 
Number of 
phenotypes 
CCCEH7 689 15 9 4 
TUSCON8 826 2 6 4 
PASTURE9 953 6 6 5 
MAAS10 1184 8 8 5 
PIAMA11 2810 8 8 5 
ALSPAC11 5760 8 8 6 
ALSPAC12 6265 7 7 6 
 
 
 
